A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-κB-regulated promoters

Genes and Development

Volumn 18, Issue 20, 2004, Pages 2518-2528

  Kassel, Olivier ^a   Schneider, Sandra ^a,c   Heilbock, Christine ^a   Litfin, Margarethe ^a   Göttlicher, Martin ^a,d   Herrlich, Peter ^a,b  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c Ganymed Pharmaceuticals   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Chromatin immunoprecipitation; Glucocorticoids; LIM domains; Repression; Transactivation

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; LIM PROTEIN; NUCLEAR PROTEIN; PHORBOL ESTER DERIVATIVE; PROTEIN DERIVATIVE; PROTEIN TRIP6; RNA; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; FOCAL ADHESION; GENE ACTIVATION; GENE CONTROL; GENE MUTATION; GENE REPRESSION; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL FRACTIONATION; CELLS, CULTURED; CHROMATIN; DNA PRIMERS; GENE EXPRESSION REGULATION; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; NF-KAPPA B; NUCLEAR PROTEINS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RECEPTORS, GLUCOCORTICOID; RNA INTERFERENCE; TRANSCRIPTION FACTOR AP-1; TWO-HYBRID SYSTEM TECHNIQUES;

ANIMALIA;

EID: 5444233785     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.322404     Document Type: Article

References (54)

1. Amano, Y., Lee, S.W., and Allison, A.C. 1993. Inhibition by glucocorticoids of the formation of interleukin-1 α, interleukin-1 β, and interleukin-6: Mediation by decreased mRNA stability. Mol. Pharmacol. 43: 176-182.
2. Barnes, P.J. 1998. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms. Clin. Sci. (Lond) 94: 557-572.
3. Beato, M., Herrlich, P., and Schütz, G. 1995. Steroid hormone receptors: Many actors in search of a plot. Cell 83: 851-857.
4. Boggaram, V., Smith, M.E., and Mendelson, C.R. 1991. Posttranscriptional regulation of surfactant protein-A messenger RNA in human fetal lung in vitro by glucocorticoids. Mol. Endocrinol. 5: 414-423.
5. Caelles, C., Gonzalez-Sancho, J.M., and Munoz, A. 1997. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes & Dev. 11: 3351-3364.
6. Cuppen, E., van Ham, M., Wansink, D.G., de Leeuw, A., Wieringa, B., and Hendriks, W. 2000. The zyxin-related protein TRIP6 interacts with PDZ motifs in the adaptor protein RIL and the protein tyrosine phosphatase PTP-BL. Eur. J. Cell Biol. 79: 283-293.
7. Da Silva, C.A., Heilbock, C., Kassel, O., and Frossard, N. 2003. Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin-1β through concerted regulation of a GRE-like and an NF-κB response element. FASEB J. 17: 2334-2336.
8. Dawid, I.B., Breen, J.J., and Toyama, R. 1998. LIM domains: Multiple roles as adapters and functional modifiers in protein interactions. Trends Genet. 14: 156-162.
9. Dilworth, F.J. and Chambon, P. 2001. Nuclear receptors coordinate the activities of chroma tin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20: 3047-3054.
10. Dong, Y., Poellinger, L., Gustafsson, J.A., and Okret, S. 1988. Regulation of glucocorticoid receptor expression: Evidence for transcriptional and posttranslational mechanisms. Mol. Endocrinol. 2: 1256-1264.
11. Fort, P., Marty, L., Piechaczyk, M., el Sabrouty, S., Dani, C., Jeanteur, P., and Blanchard, J.M. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13: 1431-1442.
12. Göttlicher, M., Heck, S., and Herrlich, P. 1998. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76: 480-489.
13. Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H.J., Herrlich, P., and Cato, A.C. 1994. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13: 4087-4095.
14. Heck, S., Bender, K., Kullmann, M., Göttlicher, M., Herrlich, P., and Cato, A.C. 1997. I κB α-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J. 16: 4698-4707.
15. Helmberg, A., Auphan, N., Caelles, C., and Karin, M. 1995. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14: 452-460.
16. Herrlich, P. 2001. Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20: 2465-2475.
17. Hoeck, W., Rusconi, S., and Groner, B. 1989. Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially expressed receptor fragment. J. Biol. Chem. 264: 14396-14402.
18. Horwitz, K.B., Jackson, T.A., Bain, D.L., Richer, J.K., Takimoto, G.S., and Tung, L. 1996. Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10: 1167-1177.
19. Jonat, C., Rahmsdorf, H.J., Park, K.K., Cato, A.C., Gebel, S., Ponta, H., and Herrlich, P. 1990. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204.
20. Karin, M. and Chang, L. 2001. AP-1-glucocorticoid receptor crosstalk taken to a higher level. J. Endocrinol. 169: 447-451.
21. Kasai, M., Guerrero-Santoro, J., Friedman, R., Leman, E.S., Getzenberg, R.H., and DeFranco, D.E. 2003. The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines. Cancer Res. 63: 4927-4935.
22. Kassel, O., Sancono, A., Kratzschmar, J., Kreft, B., Stassen, M., and Cato, A.C. 2001. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20: 7108-7116.
23. König, H., Ponta, H., Rahmsdorf, H.J., and Herrlich, P. 1992. Interference between pathway-specific transcription factors: Glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11: 2241-2246.
24. Kucera, T., Waltner-Law, M., Scott, D.K., Prasad, R., and Granner, D.K. 2002. A point mutation of the AF2 transactivation domain of the glucocorticoid receptor disrupts its interaction with steroid receptor coactivator 1. J. Biol. Chem. 277: 26098-26102.
25. Lee, J.W., Choi, H.S., Gyuris, J., Brent, R., and Moore, D.D. 1995. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol. 9: 243-254.
26. Lefstin, J.A. and Yamamoto, K.R. 1998. Allosteric effects of DNA on transcriptional regulators. Nature 392: 885-888.
27. Lernbecher, T., Muller, U., and Wirth, T. 1993. Distinct NF-κ B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365: 767-770.
28. McKay, L.I. and Cidlowski, J.A. 1998. Cross-talk between nuclear factor-κ B and the steroid hormone receptors: Mechanisms of mutual antagonism. Mol. Endocrinol. 12: 45-56.
29. McKenna, N.J., Xu, J., Nawaz, Z., Tsai, S.Y., Tsai, M.J., and O'Malley, B.W. 1999. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 69: 3-12.
30. Moras, D. and Gronemeyer, H. 1998. The nuclear receptor ligand-binding domain: Structure and function. Curr. Opin. Cell Biol. 10: 384-391.
31. Nissen, R.M. and Yamamoto, K.R. 2000. The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes & Dev. 14: 2314-2329.
32. Nix, D.A. and Beckerle, M.C. 1997. Nuclear-cytoplasmic shuttling of the focal contact protein, zyxin: A potential mechanism for communication between sites of cell adhesion and the nucleus. J. Cell Biol. 138: 1139-1147.
33. Pearce, D. and Yamamoto, K.R. 1993. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259: 1161-1165.
34. Ray, A. and Prefontaine, K.E. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κ B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. 91: 752-756.
35. Ray, D.W., Suen, C.S., Brass, A., Soden, J., and White, A. 1999. Structure/function of the human glucocorticoid receptor: Tyrosine 735 is important for transactivation. Mol. Endocrinol. 13: 1855-1863.
36. Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93: 531-541.
37. Reichardt, H.M., Tuckermann, J.P., Göttlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., and Schütz, G. 2001. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20: 7168-7173.
38. Renaud, J.P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H., and Moras, D. 1995. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378: 681-689.
39. Rogatsky, I., Zarember, K.A., and Yamamoto, K.R. 2001. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J. 20: 6071-6083.
40. Scheinman, R.I., Gualberto, A., Jewell, C.M., Cidlowski, J.A., and Baldwin Jr., A.S. 1995. Characterization of mechanisms involved in transrepression of NF-κ B by activated glucocorticoid receptors. Mol. Cell. Biol. 15: 943-953.
41. Schneikert, J., Peterziel, H., Defossez, P.A., Klocker, H., Launoit, Y., and Cato, A.C. 1996. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J. Biol Chem. 271: 23907-23913.
42. Schorpp, M., Jager, R., Schellander, K., Schenkel, J., Wagner, E.F., Weiher, H., and Angel, P. 1996. The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res. 24: 1787-1788.
43. Schüle, R., Rangarajan, P., Kliewer, S., Ransone, L.J., Bolado, J., Yang, N., Verma, I.M., and Evans, R.M. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62: 1217-1226.
44. van Dam, H., Huguier, S., Kooistra, K., Baguet, J., Vial, E., van der Eb, A.J., Herrlich, P., Angel, P., and Castellazzi, M. 1998. Autocrine growth and anchorage independence: Two complementing Jun-controlled genetic programs of cellular transformation. Genes & Dev. 12: 1227-1239.
45. Vanden Berghe, W., De Bosscher, K., Vermeulen, L., De Wilde, G., and Haegeman, G. 2002. Induction and repression of NF-κ B-driven inflammatory genes. Ernst Schering Res. Found. Workshop 40: 233-278.
46. Vayssiere, B.M., Dupont, S., Choquart, A., Petit, F., Garcia, T., Marchandeau, C., Gronemeyer, H., and Resche-Rigon, M. 1997. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol. Endocrinol. 11: 1245-1255.
47. Wang, Y. and Gilmore, T.D. 2001. LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. Biochim. Biophys. Acta 1538: 260-272.
48. Wang, Y., Dooher, J.E., Koedood Zhao, M., and Gilmore, T.D. 1999. Characterization of mouse Trip6: A putative intracellular signaling protein. Gene 234: 403-409.
49. Weg-Remers, S., Ponta, H., Herrlich, P., and König, H. 2001. Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J. 20: 4194-4203.
50. Xu, L., Glass, C.K., and Rosenfeld, M.G. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9: 140-147.
51. Yang, L., Guerrero, J., Hong, H., DeFranco, D.B., and Stallcup, M.R. 2000. Interaction of the τ2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol. Biol. Cell 11: 2007-2018.
52. Yang-Yen, H.F., Chambard, J.C., Sun, Y.L., Smeal, T., Schmidt, T.J., Drouin, J., and Karin, M. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215.
53. Yi, J. and Beckerle, M.C. 1998, The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis. Genomics 49: 314-316.
54. Zhao, M.K., Wang, Y., Murphy, K., Yi, J., Beckerle, M.C., and Gilmore, T.D. 1999. LIM domain-containing protein trip6 can act as a coactivator for the v-Rel transcription factor. Gene Expr. 8: 207-217.